Effects of Chronic Renal Failure on Kidney Drug Transporters and Cytochrome P450 in Rats

被引:100
作者
Naud, Judith [1 ,2 ,5 ]
Michaud, Josee [1 ,2 ,5 ]
Beauchemin, Stephanie [1 ,5 ]
Hebert, Marie-Josee [4 ]
Roger, Michel [3 ,4 ]
Lefrancois, Stephane [1 ,5 ]
Leblond, Francois A. [1 ,5 ]
Pichette, Vincent [1 ,2 ,5 ]
机构
[1] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada
[2] Univ Montreal, Dept Pharmacol, Fac Med, Montreal, PQ H3C 3J7, Canada
[3] Univ Montreal, Dept Microbiol & Immunol, Fac Med, Montreal, PQ H3C 3J7, Canada
[4] Univ Montreal, Notre Dame Hosp, Ctr Rech, Ctr Hosp, Montreal, PQ H3C 3J7, Canada
[5] Hop Maison Neuve Rosemont, Serv Nephrol, Montreal, PQ H1T 2M4, Canada
关键词
ORGANIC ANION TRANSPORTERS; DOWN-REGULATION; INDOXYL SULFATE; IN-VIVO; GLOMERULAR SCLEROSIS; MOLECULAR ASPECTS; PROXIMAL TUBULE; UREMIC TOXINS; DIGOXIN; PROGRESSION;
D O I
10.1124/dmd.111.039115
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic renal failure (CRF) leads to decreased drug renal clearance due to a reduction in the glomerular filtration rate. However, little is known about how renal failure affects renal metabolism and elimination of drugs. Because both depend on the activity of uptake and efflux by renal transporters as well as enzymes in tubular cells, the purpose of this study was to investigate the effects of CRF on the expression and activity of select renal drug transporters and cytochrome P450. Two groups of rats were studied: control and CRF (induced by 5/6 nephrectomy). Compared with control rats, we observed reductions in the expression of both protein and mRNA of Cyp1a, sodium-dependent phosphate transport protein 1, organic anion transporter (Oat) 1, 2, and 3, OatK1/K2, organic anion-transporting polypeptide (Oatp) 1 and 4c1, P-glycoprotein, and urate transporter 1, whereas an induction in the protein and mRNA expression of Mrp2, 3, and 4 and Oatp2 and 3 was observed. Cyp3a expression remained unchanged. Similar results were obtained by incubating a human proximal tubule cell line (human kidney-2) with sera from CRF rats, suggesting the presence of uremic modulators. Finally, the renal elimination of [(3)H] digoxin and [(14)C] benzylpenicillin was decreased in CRF rats, compared with controls, as shown by a 4- and 9-fold accumulation, respectively, of these drugs in kidneys of rats in CRF. Our results demonstrate that CRF affects the expression and activity of several kidney drug transporters leading to the intrarenal accumulation of drugs and reduced renal clearance that could, at least partially, explain the tubular toxicity of many drugs.
引用
收藏
页码:1363 / 1369
页数:7
相关论文
共 42 条
[1]  
CARTIER N, 1993, J CELL SCI, V104, P695
[2]   Involvement of Mrp2/MRP2 in the species different excretion route of benzylpenicillin between rat and human [J].
Choi, M. -K. ;
Kim, H. ;
Han, Y. -H. ;
Song, I. -S. ;
Shim, C. -K. .
XENOBIOTICA, 2009, 39 (02) :171-181
[3]   Effects of 1α,25-Dihydroxyvitamin D3 on Transporters and Enzymes of the Rat Intestine and Kidney In Vivo [J].
Chow, Edwin C. Y. ;
Sun, Huadong ;
Khan, Ansar A. ;
Groothuis, Geny M. M. ;
Pang, K. Sandy .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2010, 31 (01) :91-108
[4]   Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats [J].
Deguchi, T ;
Kouno, Y ;
Terasaki, T ;
Takadate, A ;
Otagiri, M .
PHARMACEUTICAL RESEARCH, 2005, 22 (04) :619-627
[5]   Characterization of uremic toxin transport by organic anion transporters in the kidney [J].
Deguchi, T ;
Kusuhara, H ;
Takadate, A ;
Endou, H ;
Otagiri, M ;
Sugiyama, Y .
KIDNEY INTERNATIONAL, 2004, 65 (01) :162-174
[6]   Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney [J].
Deguchi, T ;
Ohtsuki, S ;
Otagiri, M ;
Takanaga, H ;
Asaba, H ;
Mori, S ;
Terasaki, T .
KIDNEY INTERNATIONAL, 2002, 61 (05) :1760-1768
[7]   Mechanisms of renal anionic drug transport [J].
El-Sheikh, Azza A. K. ;
Masereeuw, Rosalinde ;
Russel, Frans G. M. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 585 (2-3) :245-255
[8]   Roles of organic anion transporters in the progression of chronic renal failure [J].
Enomoto, Atsushi ;
Niwa, Toshimitsu .
THERAPEUTIC APHERESIS AND DIALYSIS, 2007, 11 :S27-S31
[9]   Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state [J].
Feng, Bo ;
LaPerle, Jennnifer L. ;
Chang, George ;
Varma, Manthena V. S. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (08) :939-952
[10]   LOADING DOSE OF DIGOXIN IN RENAL-FAILURE [J].
GAULT, MH ;
CHURCHILL, DN ;
KALRA, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (06) :593-597